MT2022-60: A phase II study of Pembrolizumab+ BEAM conditioning regimen before autologous stem celltransplant (ASCT) followed by pembrolizumab maintenance in patients of relapsed classic Hodgkinlymphoma

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.